magnesium-orotate and Syndrome

magnesium-orotate has been researched along with Syndrome* in 1 studies

Other Studies

1 other study(ies) available for magnesium-orotate and Syndrome

Article	Year
[Clinical value of the use of magnesium orotate in adolescents with syndrome of cardiac connective tissue dysplasia]. Kardiologiia, 2005, Volume: 45, Issue:3 According to results of clinical and instrumental investigation magnesium orotate (50 mg/day during first week and 25 mg/day thereafter) was found to be effective therapy of children with syndrome of cardiac connective tissue dysplasia (mainly with mitral valve prolapse and anomalous chordae tendineae). Topics: Adolescent; Blood Pressure; Child; Chordae Tendineae; Connective Tissue Diseases; Female; Follow-Up Studies; Heart Rate; Humans; Male; Mitral Valve Prolapse; Orotic Acid; Retrospective Studies; Syndrome; Treatment Outcome	2005

Article

Year

[Clinical value of the use of magnesium orotate in adolescents with syndrome of cardiac connective tissue dysplasia].

Kardiologiia, 2005, Volume: 45, Issue:3

According to results of clinical and instrumental investigation magnesium orotate (50 mg/day during first week and 25 mg/day thereafter) was found to be effective therapy of children with syndrome of cardiac connective tissue dysplasia (mainly with mitral valve prolapse and anomalous chordae tendineae).

Topics: Adolescent; Blood Pressure; Child; Chordae Tendineae; Connective Tissue Diseases; Female; Follow-Up Studies; Heart Rate; Humans; Male; Mitral Valve Prolapse; Orotic Acid; Retrospective Studies; Syndrome; Treatment Outcome

2005